CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Clinical trial NCT05942300 · RECRUITING

Trial details

NCT number: NCT05942300
Sponsor: Lan Coffman
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer

Start date: 2024-01-30
Primary completion: 2028-07-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.